The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
DNA Testing & Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
DNA Testing/Diagnostics is the determination of bloodlinesand the genetic diagnosis of vulnerabilities to inherited diseases.
The global DNA Testing & Diagnostics market size is expected to reach US$ 24190 million by 2029, growing at a CAGR of 11.6% from 2023 to 2029. The market is mainly driven by the significant applications of DNA Testing & Diagnostics in various end use industries. The expanding demands from the Hospital, Medical Research and Pharmacogenomics Diagnostic Testing,, are propelling DNA Testing & Diagnostics market. PCR-Based Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ISH Diagnostics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for DNA Testing & Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global DNA Testing & Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global DNA Testing & Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, DNA Testing & Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of DNA Testing & Diagnostics covered in this report include GE Healthcare, 454 Life Sciences, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Cephide and Hologic, etc.
The global DNA Testing & Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
454 Life Sciences
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Thermo Fisher Scientific
Illumina
Cephide
Hologic
Transgenomic
Siemens Healthcare
Roche Diagnostics
Qiagen
Affymetrix
Agilent Technologies
Global DNA Testing & Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global DNA Testing & Diagnostics market, Segment by Type:
PCR-Based Diagnostics
ISH Diagnostics
NGS DNA Diagnosis
Global DNA Testing & Diagnostics market, by Application
Hospital
Medical Research
Pharmacogenomics Diagnostic Testing
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of DNA Testing & Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
DNA Testing/Diagnostics is the determination of bloodlinesand the genetic diagnosis of vulnerabilities to inherited diseases.
The global DNA Testing & Diagnostics market size is expected to reach US$ 24190 million by 2029, growing at a CAGR of 11.6% from 2023 to 2029. The market is mainly driven by the significant applications of DNA Testing & Diagnostics in various end use industries. The expanding demands from the Hospital, Medical Research and Pharmacogenomics Diagnostic Testing,, are propelling DNA Testing & Diagnostics market. PCR-Based Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ISH Diagnostics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for DNA Testing & Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global DNA Testing & Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global DNA Testing & Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, DNA Testing & Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of DNA Testing & Diagnostics covered in this report include GE Healthcare, 454 Life Sciences, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Cephide and Hologic, etc.
The global DNA Testing & Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
454 Life Sciences
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Thermo Fisher Scientific
Illumina
Cephide
Hologic
Transgenomic
Siemens Healthcare
Roche Diagnostics
Qiagen
Affymetrix
Agilent Technologies
Global DNA Testing & Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global DNA Testing & Diagnostics market, Segment by Type:
PCR-Based Diagnostics
ISH Diagnostics
NGS DNA Diagnosis
Global DNA Testing & Diagnostics market, by Application
Hospital
Medical Research
Pharmacogenomics Diagnostic Testing
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of DNA Testing & Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of DNA Testing & Diagnostics
1.1 DNA Testing & Diagnostics Market Overview
1.1.1 DNA Testing & Diagnostics Product Scope
1.1.2 DNA Testing & Diagnostics Market Status and Outlook
1.2 Global DNA Testing & Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global DNA Testing & Diagnostics Market Size by Region (2018-2029)
1.4 Global DNA Testing & Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global DNA Testing & Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, DNA Testing & Diagnostics Market Size (2018-2029)
1.6.1 North America DNA Testing & Diagnostics Market Size (2018-2029)
1.6.2 Europe DNA Testing & Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific DNA Testing & Diagnostics Market Size (2018-2029)
1.6.4 Latin America DNA Testing & Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa DNA Testing & Diagnostics Market Size (2018-2029)
2 DNA Testing & Diagnostics Market by Type
2.1 Introduction
2.1.1 PCR-Based Diagnostics
2.1.2 ISH Diagnostics
2.1.3 NGS DNA Diagnosis
2.2 Global DNA Testing & Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global DNA Testing & Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global DNA Testing & Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America DNA Testing & Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe DNA Testing & Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific DNA Testing & Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America DNA Testing & Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa DNA Testing & Diagnostics Revenue Breakdown by Type (2018-2029)
3 DNA Testing & Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Medical Research
3.1.3 Pharmacogenomics Diagnostic Testing
3.2 Global DNA Testing & Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global DNA Testing & Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global DNA Testing & Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America DNA Testing & Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe DNA Testing & Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific DNA Testing & Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America DNA Testing & Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa DNA Testing & Diagnostics Revenue Breakdown by Application (2018-2029)
4 DNA Testing & Diagnostics Competition Analysis by Players
4.1 Global DNA Testing & Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA Testing & Diagnostics as of 2022)
4.3 Date of Key Players Enter into DNA Testing & Diagnostics Market
4.4 Global Top Players DNA Testing & Diagnostics Headquarters and Area Served
4.5 Key Players DNA Testing & Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 DNA Testing & Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare DNA Testing & Diagnostics Products, Services and Solutions
5.1.4 GE Healthcare DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Recent Developments
5.2 454 Life Sciences
5.2.1 454 Life Sciences Profile
5.2.2 454 Life Sciences Main Business
5.2.3 454 Life Sciences DNA Testing & Diagnostics Products, Services and Solutions
5.2.4 454 Life Sciences DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 454 Life Sciences Recent Developments
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Profile
5.3.2 Abbott Laboratories Main Business
5.3.3 Abbott Laboratories DNA Testing & Diagnostics Products, Services and Solutions
5.3.4 Abbott Laboratories DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Beckman Coulter Recent Developments
5.4 Beckman Coulter
5.4.1 Beckman Coulter Profile
5.4.2 Beckman Coulter Main Business
5.4.3 Beckman Coulter DNA Testing & Diagnostics Products, Services and Solutions
5.4.4 Beckman Coulter DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Beckman Coulter Recent Developments
5.5 Bio-Rad Laboratories
5.5.1 Bio-Rad Laboratories Profile
5.5.2 Bio-Rad Laboratories Main Business
5.5.3 Bio-Rad Laboratories DNA Testing & Diagnostics Products, Services and Solutions
5.5.4 Bio-Rad Laboratories DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Laboratories Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific DNA Testing & Diagnostics Products, Services and Solutions
5.6.4 Thermo Fisher Scientific DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 Illumina
5.7.1 Illumina Profile
5.7.2 Illumina Main Business
5.7.3 Illumina DNA Testing & Diagnostics Products, Services and Solutions
5.7.4 Illumina DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Illumina Recent Developments
5.8 Cephide
5.8.1 Cephide Profile
5.8.2 Cephide Main Business
5.8.3 Cephide DNA Testing & Diagnostics Products, Services and Solutions
5.8.4 Cephide DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Cephide Recent Developments
5.9 Hologic
5.9.1 Hologic Profile
5.9.2 Hologic Main Business
5.9.3 Hologic DNA Testing & Diagnostics Products, Services and Solutions
5.9.4 Hologic DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Hologic Recent Developments
5.10 Transgenomic
5.10.1 Transgenomic Profile
5.10.2 Transgenomic Main Business
5.10.3 Transgenomic DNA Testing & Diagnostics Products, Services and Solutions
5.10.4 Transgenomic DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Transgenomic Recent Developments
5.11 Siemens Healthcare
5.11.1 Siemens Healthcare Profile
5.11.2 Siemens Healthcare Main Business
5.11.3 Siemens Healthcare DNA Testing & Diagnostics Products, Services and Solutions
5.11.4 Siemens Healthcare DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Siemens Healthcare Recent Developments
5.12 Roche Diagnostics
5.12.1 Roche Diagnostics Profile
5.12.2 Roche Diagnostics Main Business
5.12.3 Roche Diagnostics DNA Testing & Diagnostics Products, Services and Solutions
5.12.4 Roche Diagnostics DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Roche Diagnostics Recent Developments
5.13 Qiagen
5.13.1 Qiagen Profile
5.13.2 Qiagen Main Business
5.13.3 Qiagen DNA Testing & Diagnostics Products, Services and Solutions
5.13.4 Qiagen DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Qiagen Recent Developments
5.14 Affymetrix
5.14.1 Affymetrix Profile
5.14.2 Affymetrix Main Business
5.14.3 Affymetrix DNA Testing & Diagnostics Products, Services and Solutions
5.14.4 Affymetrix DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Affymetrix Recent Developments
5.15 Agilent Technologies
5.15.1 Agilent Technologies Profile
5.15.2 Agilent Technologies Main Business
5.15.3 Agilent Technologies DNA Testing & Diagnostics Products, Services and Solutions
5.15.4 Agilent Technologies DNA Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Agilent Technologies Recent Developments
6 North America
6.1 North America DNA Testing & Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe DNA Testing & Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific DNA Testing & Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America DNA Testing & Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa DNA Testing & Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 DNA Testing & Diagnostics Market Dynamics
11.1 DNA Testing & Diagnostics Industry Trends
11.2 DNA Testing & Diagnostics Market Drivers
11.3 DNA Testing & Diagnostics Market Challenges
11.4 DNA Testing & Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
